Viewing Study NCT04795869


Ignite Creation Date: 2025-12-24 @ 10:55 PM
Ignite Modification Date: 2025-12-27 @ 11:24 AM
Study NCT ID: NCT04795869
Status: WITHDRAWN
Last Update Posted: 2023-10-10
First Post: 2021-03-10
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Brentuximab Vedotin and Pembrolizumab in Treating Patients With Recurrent Peripheral T-Cell Lymphoma
Sponsor: Northwestern University
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module